XML 190 R49.htm IDEA: XBRL DOCUMENT
v3.26.1

Basic and diluted net loss per share (Tables) | 9 Months Ended | 12 Months Ended
--- | --- | ---
Mar. 31, 2026 | Jun. 30, 2025
Exascale Labs Inc. [Member] |  |
Schedule of basic share and diluted |
Schedule of basic share and diluted |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | For the Three Months Ended March 31, |  |  | For the Nine Months Ended March 31, |
--- | --- | --- | --- | --- | --- | ---
|  | 2025 |  |  | 2026 |  |  | 2025 |  |  | 2026 |
Numerator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net loss attributable to ordinary shareholders |  | $ | (1,537,059 | ) |  | $ | (2,632,431 | ) |  | $ | (6,178,537 | ) |  | $ | (7,916,977 | )
Denominator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Denominator for basic and diluted loss per share |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted-average ordinary shares outstanding(i) |  |  | 1,500 |  |  |  | 1,500 |  |  |  | 1,500 |  |  |  | 1,500 |
Basic and diluted(ii) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic and diluted loss per share |  | $ | (1,024.70 | ) |  | $ | (1,754.95 | ) |  | $ | (4,119.02 | ) |  | $ | (5,277.98 | )
(i) | In January 2026, the Company adopted an Amended and Restated Certificate of Incorporation, which established a dual-class ordinary share structure. Under this new structure, the Company’s equity is divided into 303 Class A ordinary shares and 1,197 Class B ordinary shares, which are entitled to one (1) vote and twenty (20) votes per share, respectively. Despite the differential in voting power, Class A and Class B ordinary shares rank pari passu in all other respects, sharing ratably in dividends and any distributions upon liquidation.
(ii) | During the three and nine months ended March 31, 2025 and 2026, diluted net loss per share is calculated in the same manner as basic net loss per share, as the Company was in a net loss position and all potential ordinary shares were anti-dilutive.
Schedule of basic share and diluted |  |  |  |  |  |  |  |
|  | For the years ended June 30, |
|  | 2024 |  |  | 2025 |
Numerator: |  |  |  |  |  |  |  |
Net loss attributable to ordinary shareholders |  | $ | (4,956,347 | ) |  | $ | (7,659,667 | )
Denominator: |  |  |  |  |  |  |  |
Denominator for basic and diluted loss per share |  |  |  |  |  |  |  |
Weighted-average ordinary shares outstanding, Basic and diluted* |  |  | 1,500 |  |  |  | 1,500 |
Basic and diluted loss per share |  | $ | (3,304.23 | ) |  | $ | (5,106.44 | )
| * | The Company’s share-based compensation awards are expected to be settled through transfers of existing ordinary shares held by the controlling shareholder, rather than through the issuance of new shares by the Company. The underlying ordinary shares are included in issued and outstanding shares as of the balance sheet date; accordingly, such settlement is not expected to increase the Company’s total issued and outstanding shares. During the years ended June 30, 2024 and 2025, diluted net loss per share is calculated in the same manner as basic net loss per share.

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | dei_LegalEntityAxis=cik0002065779_ExascaleLabsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |